Upgrade to SI Premium - Free Trial

BMO Capital on Eli Lilly's (LLY) Positioning for 2H26

September 9, 2026 8:11 AM
BMO Capital analyst Evan Seigerman reiterated an Outperform rating and $1,400.00 price target on Eli Lilly (NYSE: LLY).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments